AbCellera Biologics Inc. Quarterly Depreciation in USD from Q1 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: AbCellera Biologics Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q3 2024.
AbCellera Biologics Inc. Depreciation for the quarter ending September 30, 2024 was $3.8M, a 22.6% increase year-over-year.
AbCellera Biologics Inc. Depreciation for the twelve months ending September 30, 2024 was $14.2M, a 20.8% increase year-over-year.
AbCellera Biologics Inc. annual Depreciation for 2023 was $12.8M, a 42.5% increase from 2022.
AbCellera Biologics Inc. annual Depreciation for 2022 was $8.95M, a 103% increase from 2021.
AbCellera Biologics Inc. annual Depreciation for 2021 was $4.4M, a 90% increase from 2020.

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$14.2M	$3.8M	+$700K	+22.6%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-04
Q2 2024	$13.5M	$3.4M	+$400K	+13.3%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$13.1M	$3.16M	+$297K	+10.4%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$12.8M	$3.8M	+$1.04M	+37.6%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-20
Q3 2023	$11.7M	$3.1M	+$600K	+24%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-04
Q2 2023	$11.1M	$3M	+$700K	+30.4%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-06
Q1 2023	$10.4M	$2.86M	+$1.47M	+105%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	$8.95M	$2.76M	+$1.5M	+119%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-20
Q3 2022	$7.45M	$2.5M	+$1.3M	+108%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	$6.15M	$2.3M	+$1.2M	+109%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$4.95M	$1.39M	+$551K	+65.6%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$4.4M	$1.26M	+$461K	+57.5%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-20
Q3 2021	$3.94M	$1.2M	+$1.2M		Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	$2.74M	$1.1M	$0	0%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$2.74M	$840K	+$425K	+102%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$2.32M	$802K			Oct 1, 2020	Dec 31, 2020	10-K	2023-02-21
Q3 2020		$0			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		$1.1M			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020		$415K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.